Bioclinica, a leading provider of science and technology expertise to assist the life science industry in advancing the development of medical therapies, announced today that Michael O’Neal, M.D., Chief Medical Officer, Head of Oncology, has been recognized by PharmaVOICE magazine as one of the “100 Most Inspiring People in the Life-Sciences Industry.”
PRINCETON, N.J. (PRWEB) AUGUST 02, 2019
Bioclinica, a leading provider of science and technology expertise to assist the life science industry in advancing the development of medical therapies, announced today that Michael O’Neal, M.D., Chief Medical Officer, Head of Oncology, has been recognized by PharmaVOICE magazine as one of the “100 Most Inspiring People in the Life-Sciences Industry.” Dr. O’Neal was recognized for his leadership at Bioclinica and his contributions to the field of medical imaging in oncology clinical trials over his 30-year career.
“Dr. O’Neal is a true leader and expert in medical imaging for clinical trials; and he inspires his colleagues and clients every day,” said David Herron, President & CEO of Bioclinica. “During his 17 years with Bioclinica, he has developed and championed improved standards that enable research sites to produce comparable study data across the globe, which is essential to successful trials and regulatory approvals of new therapies.”
Drawing on extensive clinical training in internal medicine and diagnostic radiology, Dr. O’Neal provides leadership to Bioclinica’s on-staff radiologists, oncologists, and clinical project management teams. He works closely with sponsors and their teams to ensure the latest industry criteria are operationalized so that imaging is performed according to the study protocol for every patient a site enrolls. Dr. O’Neal’s team currently manages more than 600 active oncology clinical trials.
The PharmaVOICE 100 list, published annually, celebrates inspirational, motivational, and transformative individuals in life sciences who positively impact their colleagues, peers, organizations, and the industry.
About Bioclinica
Bioclinica is a global life science provider that utilizes science and technology to bring clarity to clinical trials – helping companies to develop new life-improving therapies more efficiently and safely. Successful clinical trials require the ability to see key details and uncover hidden insights, and Bioclinica’s hundreds of experienced scientific, medical, and domain experts bring unmatched insight across the development lifecycle, from the initial protocol to post-approval. The company’s cloud-based offerings include medical imaging and cardiac safety services; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site and patient payments and budget forecasting; pharmacovigilance and trial management. A true multifaceted partner to trial sponsors and Contract Research Organizations (CROs), Bioclinica offers a global network of research sites and patient recruitment services to provide committed, detail-focused service through all stages of drug development. The company’s thousands of employees serve more than 400 pharmaceutical, biotechnology and device organizations – including all the top 20 biopharmaceutical companies and leading CROs – through a network of offices in the U.S., Europe, and Asia.
“Dr. O’Neal is a true leader and expert in medical imaging for clinical trials; and he inspires his colleagues and clients every day,” said David Herron, President & CEO of Bioclinica.
